Literature DB >> 1255479

Opiate receptor interactions of benzomorphans in rat brain homogenates.

C B Pert, S H Snyder, E L May.   

Abstract

Minor structural variations of benzomorphans opiates are associated with striking, unpredictable shifts in the relative extent of agonist or antagonist properties in vivo. The relative abilities of a number of benzomorphans in inhibit 3H-naloxone binding in the absence and presence of sodium in vitro show some correlations with their pharmacologic properties in vivo, although distinct exceptions exist. The ability of opiate agonists to inhibit 3H-naloxone binding is greatly reduced by sodium, while pure antagonists are affected very little, if at all, and mixed agonist-antagonist benzomorphans display an intermediate response.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1255479

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Comparison of the receptor binding characteristics of opiate agonists interacting with mu- or kappa-receptors.

Authors:  H W Kosterlitz; F M Leslie
Journal:  Br J Pharmacol       Date:  1978-12       Impact factor: 8.739

2.  Kappa opiate receptors localized by autoradiography to deep layers of cerebral cortex: relation to sedative effects.

Authors:  R R Goodman; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

3.  Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia.

Authors:  G W Pasternak
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

4.  Interaction of leucine enkephalin with (3H)naloxone binding in rat brain: evidence for an opioid receptor complex.

Authors:  R B Rothman; T C Westfall
Journal:  Neurochem Res       Date:  1983-07       Impact factor: 3.996

5.  Visualization and solubilization of rat brain opiate receptors with a "kappa" ligand selectivity pattern.

Authors:  R Quirion; W D Bowen; M Herkenham; C B Pert
Journal:  Cell Mol Neurobiol       Date:  1982-12       Impact factor: 5.046

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.